Drug-eluting stents (DES) were developed to overcome in-stent restenosis (ISR), which has
long been considered the main complication limiting the long-term efficacy of coronary …

Oligometastatic disease represents a clinical and anatomical manifestation between
localised and polymetastatic disease. In prostate cancer, as with other cancers, recognition …

Objectives: The aim of this study was to investigate the efficacy of a paclitaxel-eluting
balloon (PEB) for the treatment of sirolimus-eluting stent (SES) restenosis. Background …

Aims In many countries, drug-eluting stent implantation is the dominant interventional
strategy. We evaluated the clinical, angiographic, procedural, and intravascular ultrasound …

In the past decade, tremendous progress has been made in reducing the incidence of
restenosis with the advent of the drug-eluting stent (DES). With “plain old balloon …

Over the past decade the introduction of drug-eluting stents (DESs) has revolutionised the
treatment of coronary artery disease. However, in recent years concern has arisen over the …

Background: Stent fracture is one of the possible causes of restenosis after sirolimus‐eluting
stents (SES) implantation. The aim of our study was to evaluate the prevalence and clinical …

Middle aortic syndrome (MAS) is a clinical condition generated by segmental narrowing of
the abdominal or distal descending thoracic aorta. MAS may be acquired, caused by …

Background The aim of this study was to investigate the efficacy and safety of paclitaxel-
coated balloon (PCB) for the treatment of the bare-metal stent restenosis (BMS-ISR) and …

Aims: The purpose of this single centre registry is to assess safety and feasibility of the
frequency domain optical coherence tomography (FD-OCT) system during coronary …